BioCentury
ARTICLE | Clinical News

Humira adalimumab regulatory update

May 10, 2004 7:00 AM UTC

The EMEA recommended approval for a Humira label extension to include reducing the rate of progression of joint damage and improving physical function in adults with rheumatoid arthritis (RA). The mon...